Michael Pourdehnad

Company: Bristol Myers Squibb

Job title: VP, Early Clinical Development, Hematology/Oncology & Cell Therapy

Bio:

Seminar: Clinical Activity of Novel Celmod CC-99282 in Patients with Non-Hodgkin Lymphoma

For more information on this session, please download the full event guide.

Day: Day One